The Bile Duct Cancer Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for bile duct cancer has seen significant growth lately. It is expected to rise from $2.39 billion in 2024 to $2.60 billion in 2025, with a compound annual growth rate (CAGR) of 9.1%.
The Bile Duct Cancer Global Market is forecasted to reach a size of $3.63 billion in 2029, with a compound annual growth rate (CAGR) of 8.7%.
Download Your Free Sample of the 2025 Bile Duct Cancer Market Report and Uncover Key Trends Now!The key drivers in the bile duct cancer market are:
• Increasing incidence of bile duct and liver cancer
• Rise in the occurrence of biliary tract cancers (BTCs)
• Surge in research and development activities in this field
• Growing demand for more advanced treatments in bile duct cancer.
The bile duct cancer market covered in this report is segmented –
1) By Type: Extrahepatic Bile Duct Cancer (eCCA), Intrahepatic Bile Duct Cancer (iCCA)
2) By Treatment Type: Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy, Immunotherapy
3) By Stage of Disease: Localized, Regional, Distant
4) By Diagnosis Type: Imaging Tests, Biopsy, Blood Tests
5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes
Subsegments:
1) By Extrahepatic Bile Duct Cancer (eCCA): Perihilar Cholangiocarcinoma (Klatskin Tumor), Distal Cholangiocarcinoma
2) By Intrahepatic Bile Duct Cancer (iCCA): Mass-Forming iCCA, Periductal Infiltrating iCCA, Intraductal Growth iCCA
The key trends in the bile duct cancer market are:
• Advancements in diagnostic techniques are reshaping the market.
• The development of medical technology is a prominent emerging trend.
• There is a noticeable trend towards advancing endoscopic imaging techniques.
• Personalized medicine approaches are becoming increasingly popular.
Major players in the bile duct cancer market are:
• AbbVie Inc.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Merck & Co. Inc.
• Boehringer Ingelheim International GmbH
• Eisai Co. Ltd.
• Genentech Inc.
• Jazz Pharmaceuticals plc
• Incyte Corporation
• Exelixis Inc.
• Hutchison China MediTech Limited
• Zymeworks Inc.
• Mirati Therapeutics Inc.
• RenovoRx Inc.
• Spectrum Pharmaceuticals Inc.
• Specialised Therapeutics Pty Ltd
• Taiho Pharmaceutical Co. Ltd.
North America was the largest region in the bile duct cancer market in 2024